1 Min Read
March 5 (Reuters) - Obalon Therapeutics Inc:
* OBALON ANNOUNCES FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS
* Q4 LOSS PER SHARE $0.60 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.